Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
| ▸ | PPARA | Q07869 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8137883 | 0.83 | PTGS2 (0.34) | PTGDR2PTGS2 | |
| SCHEMBL8135352 | 0.82 | PDE4A (0.34) | PTGDR2CHRM1PTGS2 | |
| SCHEMBL17026934 | 0.80 | PPARA (0.33) | PTGDR2PPARA | |
| SCHEMBL6270480 | 0.75 | PTGS1 (0.38) | PTGDR2PTGS1PTGS2 | |
| SCHEMBL7090383 | 0.74 | OPRD1 (0.32) | CHRM1 | |
| SCHEMBL17026999 | 0.73 | PPARG (0.36) | PTGDR2PPARA | |
| SCHEMBL7093856 | 0.73 | PTGDR2 (0.33) | PTGDR2PTGS1PTGS2 | |
| SCHEMBL7093857 | 0.73 | CHRM1 (0.33) | PTGDR2CHRM1PTGS1PTGS2 | |
| SCHEMBL18580411 | 0.72 | PTGDR2 (0.33) | PTGDR2PPARA | |
| SCHEMBL6557433 | 0.72 | ALDH1A1 (0.33) | PTGDR2PTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6608217-B2 | Process for producing 4-substituted benzopyran derivatives | CENTRAL GLASS COMPANY, LIMITED (JP) | 2003-08-19 | — | — | US | disclosed |
| US-20030109574-A1 | Process for producing 4-substituted benzopyran derivatives | CENTRAL GLASS COMPANY, LIMITED (JP) | 2003-06-12 | — | — | US | disclosed |
| EP-1298129-A2 | Process for producing 4-sustituted benzopyran derivatives | Central Glass Company, Limited (JP) | 2003-04-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030109574-A1 | Process for producing 4-substituted benzopyran derivatives | ACSL4, HAO2, ACSL6 | PTGDR2 1658/4885CHRM1 3098/4885PTGS1 1801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.